Michael Weichenthal: Clinical Trials

1 trial sponsored by Michael Weichenthal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Michael Weichenthal: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PTK/ZK in Disseminated Malignant Melanoma
PTK787/ZK 222584, Dacarbazine - Melanoma
Phase 1 / Phase 2TerminatedMichael Weichenthal92006-12-012021-10-06

Conditions studied

Melanoma (1)

Interventions

Dacarbazine (1)  ·  vatalanib (1)

Countries

Germany (1)